EDHF: A cytochrome P450 metabolite in coronary arteries

被引:35
作者
Fisslthaler, B [1 ]
Fleming, I [1 ]
Busse, R [1 ]
机构
[1] Univ Frankfurt Klinikum, Inst Kardiovask Physiol, D-6000 Frankfurt, Germany
关键词
D O I
10.1016/S0146-0005(00)80048-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endothelium-dependent relaxation cannot be fully attributed to the release of nitric oxide or prostacyclin (PGI2). In resistance-sized vessels and coronary arteries a high proportion of endothelium-dependent relaxation, in response to agonist-induced or mechanical stimulation of endothelial cells, can be attributed to the release of 1 or more endothelium-derived hyperpolarizing factor (EDHF). In coronary arteries EDHF has been pharmacologically characterized as a cytochrome P450 (CYP)-derived metabolite of arachidonic acid. We show here that a CYP 2C arachidonic acid epoxygenase, homologous to CYP 2C8/9, is expressed in cultured human endothelial cells and native porcine coronary artery endothelial cells. Down-regulation of CYP 2C protein by transfection of porcine coronary arteries with anti-sense oligonucleotides decreased EDHF-mediated vascular respouses while EDHF- mediated hyperpolarisation and relaxation were potentiated by the CYP- inducing compound β-naphthoflavone. Thus, CYP 2C appears to play a crucial role in the generation of EDHF-mediated responses in porcine coronary arteries. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 21 条
[21]   Interactions between endothelium-derived relaxing factors in the rat hepatic artery:: focus on regulation of EDHF [J].
Zygmunt, PM ;
Plane, F ;
Paulsson, M ;
Garland, CJ ;
Högestätt, ED .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (05) :992-1000